Literature DB >> 33940234

The μ-opioid receptor induces miR-21 expression and is ERK/PKCμ-dependent.

Jen-Kuan Chang1, William D Cornwell1, Thomas J Rogers2.   

Abstract

Micro RNA-21 (miR-21) is believed to perform an important role in the transition from inflammation to resolution in the innate immune response. The biochemical basis for the induction of miR-21 remains uncertain. However, the activation of the μ-opioid receptor (MOR) induces the expression of miR-21. Our results show that human monocytes treated with μ-opioid agonists exhibit a significant increase in miR-21 expression. We found that MOR-induction of miR-21 requires the activation of the Ras-Raf-MEK-ERK signaling cascade, and to our surprise, the activation of PKCμ (PKD1). These results are significant given the role of miR-21 in the sensitivity to pain.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MiR-21; Monocyte; PKCμ; PKD; microRNA

Mesh:

Substances:

Year:  2021        PMID: 33940234      PMCID: PMC8169580          DOI: 10.1016/j.jneuroim.2021.577585

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.221


  69 in total

Review 1.  Opioid G protein-coupled receptors: signals at the crossroads of inflammation.

Authors:  Thomas J Rogers; Phillip K Peterson
Journal:  Trends Immunol       Date:  2003-03       Impact factor: 16.687

Review 2.  The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis.

Authors:  D J Carr; T J Rogers; R J Weber
Journal:  Proc Soc Exp Biol Med       Date:  1996-12

3.  Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells.

Authors:  Heike L Rittner; Dominika Labuz; Michael Schaefer; Shaaban A Mousa; Stefan Schulz; Michael Schäfer; Christoph Stein; Alexander Brack
Journal:  FASEB J       Date:  2006-10-23       Impact factor: 5.191

4.  Immune conditions associated with CD4+ T effector-induced opioid release and analgesia.

Authors:  Jérôme Boué; Catherine Blanpied; Marilena Djata-Cabral; Lucette Pelletier; Nathalie Vergnolle; Gilles Dietrich
Journal:  Pain       Date:  2011-12-19       Impact factor: 6.961

5.  Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes.

Authors:  Xu Wang; Li Ye; Yu Zhou; Man-Qing Liu; Dun-Jin Zhou; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.

Authors:  T Chijiwa; A Mishima; M Hagiwara; M Sano; K Hayashi; T Inoue; K Naito; T Toshioka; H Hidaka
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

7.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

8.  Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

Authors:  Dennis Löffler; Katja Brocke-Heidrich; Gabriele Pfeifer; Claudia Stocsits; Jörg Hackermüller; Antje K Kretzschmar; Renate Burger; Martin Gramatzki; Conny Blumert; Kay Bauer; Helena Cvijic; A Kerstin Ullmann; Peter F Stadler; Friedemann Horn
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

9.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.

Authors:  Fanyin Meng; Roger Henson; Hania Wehbe-Janek; Kalpana Ghoshal; Samson T Jacob; Tushar Patel
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

10.  Protein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress.

Authors:  Arunkumar Asaithambi; Muhammet Ay; Huajun Jin; Anamitra Gosh; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.